Clinical trial
Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced…
NCT00374660 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00374660 |
|---|---|
| Title | Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors |
| Official title | Phase I-II Clinical and Pharmacokinetic Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Irofulven |
| Enrollment | 63 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 11, 2006 |
| Last update posted | Dec 8, 2021 |
| Countries | France |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: